Skip to main content
. Author manuscript; available in PMC: 2012 Apr 25.
Published in final edited form as: Eur J Pharmacol. 2011 Feb 12;657(1-3):159–166. doi: 10.1016/j.ejphar.2011.01.060

Fig. 4. TNF-4.0 h causes increased GSK3β activity.

Fig. 4

Lung lysate is assessed for un-phospho-β-catenin33/37, β-catenin and β-actin in the Control (N=14), TNF-4.0 h (N=6), SB216763 (SB, N=6) and SB216763+TNF-4.0 h (N=6) groups. A representative Western blot is shown. The data is expressed as the un-phospho-β-catenin33/37/β-catenin (RDU ratio).

*= different (P< 0.05) from the Control group using the ANOVA with Holm-Sidak post-hoc multiple comparison test.